Effects of troglitazone on HepG2 viability and mitochondrial function.

@article{Tirmenstein2002EffectsOT,
  title={Effects of troglitazone on HepG2 viability and mitochondrial function.},
  author={Mark A. Tirmenstein and Catherine X. J. Hu and Tracy L Gales and Beverly E. Maleeff and Padma Kumar Narayanan and Edit Kurali and Timothy K. Hart and Heath C Thomas and Lester W. Schwartz},
  journal={Toxicological sciences : an official journal of the Society of Toxicology},
  year={2002},
  volume={69 1},
  pages={131-8}
}
Troglitazone (TRO), a member of the thiazolidinedione class of drugs, has been associated with hepatotoxicity in patients. The following in vitro study was conducted to investigate the effects of TRO on mitochondrial function and viability in a human hepatoma cell line, HepG2. TRO induced a concentration- and time-dependent increase in cell death, as measured by lactate dehydrogenase release. Exposure to 50 or 100 micro M TRO produced total loss of cell viability within 5 h. Preincubation of… CONTINUE READING
36 Extracted Citations
33 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 36 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 33 references

Troglitazone

  • C. M. Spencer, A. Markham
  • Drugs 54, 89–101.
  • 1997
Highly Influential
2 Excerpts

Similar Papers

Loading similar papers…